BCRP

From WikiMD's Wellness Encyclopedia

Breast Cancer Resistance Protein (BCRP)

The Breast Cancer Resistance Protein (BCRP), also known as ATP-binding cassette sub-family G member 2 (ABCG2), is a protein that in humans is encoded by the *ABCG2* gene. BCRP is a member of the ATP-binding cassette (ABC) transporter family, which is involved in the transport of various molecules across extracellular and intracellular membranes.

Function[edit | edit source]

BCRP functions as a xenobiotic transporter, playing a crucial role in the efflux of drugs and xenobiotics from cells. It is known for its ability to confer multidrug resistance (MDR) to cancer cells by actively transporting a wide range of chemotherapeutic agents out of the cells, thereby reducing their intracellular concentrations and effectiveness.

BCRP is expressed in various tissues, including the placenta, liver, intestine, and blood-brain barrier, where it serves protective roles by limiting the absorption and distribution of potentially harmful substances.

Clinical Significance[edit | edit source]

BCRP is of significant interest in the field of oncology due to its role in drug resistance. Overexpression of BCRP in cancer cells is associated with resistance to several anticancer drugs, including mitoxantrone, topotecan, and methotrexate. This makes BCRP a target for overcoming drug resistance in cancer therapy.

In addition to its role in cancer, BCRP is also involved in the pharmacokinetics of various drugs, affecting their absorption, distribution, metabolism, and excretion (ADME). It is important in the context of drug-drug interactions and personalized medicine.

Genetic Variability[edit | edit source]

The *ABCG2* gene exhibits genetic polymorphisms that can influence the expression and function of BCRP. These polymorphisms can affect an individual's response to drugs and susceptibility to certain diseases. For example, the Q141K polymorphism is associated with altered BCRP function and has been studied in relation to drug pharmacokinetics and disease risk.

Research and Development[edit | edit source]

Research on BCRP continues to explore its role in drug resistance and its potential as a therapeutic target. Inhibitors of BCRP are being developed to enhance the efficacy of chemotherapeutic agents by preventing drug efflux from cancer cells.

Also see[edit | edit source]

Template:Drug resistance

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD